AMA Releases Provisional CPT Codes for COVID-19 Booster Vaccines
AMA Releases Provisional CPT Codes for COVID-19 Booster Vaccines
Three new CPT codes for COVID boosters have been released by the AMA: one vaccine product code and two administration codes. The booster candidates are from products developed by Pfizer and Sanofi-GlaxoSmithKline. With the addition of these codes, a total of 35 CPT codes have been released for COVID-19 vaccine reporting. The release of the updates now will allow providers and systems to be ready for the potential authorization by the FDA.
The booster candidate from Pfizer, which is for use in children ages 5-11 who have completed a primary series of COVID-19 vaccines, received the Emergency Use Authorization (EUA) from the FDA. The new code is for administration of the booster dose.
The CPT codes for the Sanofi-GSK candidate are provisional, and they will become effective if and when the FDA grants an EUA. The Sanofi-GSK booster candidate is for persons 18 years old or older who have completed a primary series of COVID-19 vaccines. There are new product and administration codes for this vaccine.
Below are the codes and long descriptions of the COVID vaccine CPT codes 2022:
Product and administration codes for Sanofi-GSK booster candidate
| Code | Description |
| 91310 | “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative-free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use” (AMA, 2022) |
| 0104A | “Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative-free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose” (AMA, 2022) |
Administration code for Pfizer booster candidate
| Code | Description |
| 0074A | “Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative-free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose” (AMA, 2022) |
The AMA COVID-19 CPT website has additional information, including a vaccine finder and special editions of CPT Assistant dedicated to COVID-19 vaccine codes.
CPT Appendix Q, which includes a table of all COVID-19 vaccine codes, descriptions, manufacturers, dosing intervals, and other information, has been updated to include the new codes.
For the latest news on the COVID vaccine CPT codes 2022 and other coding updates, check out our COVID-19 Resource Center.
